AndrewWangMD

Cardiology • Durham, NC

Interventional Cardiology

Professor of Medicine, Duke University

Join to view full profile

Dr. Wang is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Wang's full profile

Already have an account?

Office
Duke University Hospital
2301 Erwin Rd, HAFS 8678
Durham, NC 27710

Education & Training

Duke University HospitalFellowship, Cardiovascular Disease, 1995 - 1997
Duke University HospitalFellowship, Cardiovascular Disease, 1993 - 1994
Johns Hopkins UniversityResidency, Internal Medicine, 1990 - 1993
Duke University School of MedicineClass of 1990

Certifications & Licensure

NC State Medical License 1995 - 2025
FL State Medical License 2013 - 2015
MD State Medical License 1994 - 1995
American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

Fellow (FACC) American College of Cardiology

Clinical Trials

Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients With Functional Mitral Regurgitation (The COAPT Trial) and COAPT CAS Start of enrollment: 2012 Aug 01
Active, not recruiting
Not Applicable

Publications & Presentations

PubMed

450 citations
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
Iacopo Olivotto, Artur Oreziak, Roberto Barriales-Villa, Theodore P. Abraham, Ahmad Masri
Lancet. 2020-09-12
16 citations
Long-term outcomes of mitral regurgitation by type and severity.
Zainab Samad, Linda K. Shaw, Matthew Phelan, Donald D. Glower, Mads Ersbøll
American Heart Journal. 2018-05-18
4 citations
Medical therapies for hypertrophic cardiomyopathy: Current state of the art.
Milind Y Desai, Anjali Owens, Andrew Wang
Progress in Cardiovascular Diseases. 2023-08-22

Journal Articles

Injection Drug Use-Associated Infective Endocarditis—Reply
Jeffrey G Gaca, Andrew Wang, JAMA
Incidence of Infective Endocarditis in Patients Considered at Moderate Risk
Andrew Wang, MD, European Heart Journal
Management Considerations in Infective Endocarditis
Andrew Wang, Jeffrey G Gaca, JAMA

Press Mentions

Aggressive Alcohol Septal Ablation for HCM Holds up, Pacemakers NotwithstandingSeptember 14th, 2022
MyoKardia Reports Third Quarter 2019 Financial ResultsNovember 4th, 2019
MyoKardia Presents 36-Week Data from PIONEER-OLE Study of Mavacamten at the European Society of Cardiology Congress 2019August 31st, 2019
Join now to see all

Professional Memberships

American College of Cardiology - ACC
Member